Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44381 clinical trials with a EudraCT protocol, of which 7393 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (26,035)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

26,035 result(s) found. Displaying page 229 of 1,302.

EudraCT Number: 2006-004817-16

Sponsor Protocol Number: MACI00206

Start Date*: 2008-01-23

Sponsor Name:Genzyme Europe B.V.

Full Title: A Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study to Demonstrate the Superiority of Matrix-induced Autologous Chondrocyte Implantation (MACI® implant) versus Arthroscopic Mi...

Medical condition: Symptomatic Articular Cartilage Defects of the Femoral Condyle including the Trochlea. osteochondritis dissecans lesions that do not require a bone graft.

Disease:	Version	SOC Term	Classification Code	Term	Level
	13.1	10028395 - Musculoskeletal and connective tissue disorders	10031231	Osteochondritis dissecans	LLT
	13.1	10022117 - Injury, poisoning and procedural complications	10007705	Cartilage damage	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed) CZ (Completed) SE (Completed) NL (Completed) PL (Completed) DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-004997-10

Sponsor Protocol Number: 206207-011

Start Date*: 2007-01-09

Sponsor Name:Allergan Limited

Full Title: A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Ap...

Medical condition: Diabetic macular edema

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004853	10057915	Diabetic macular oedema	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) HU (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2007-006252-19	Sponsor Protocol Number: 1.0.	Start Date*: 2008-07-24
Sponsor Name:Univ.-Prof. DDr. Norbert Jakse, Universitätszahnklinik Graz, Dep. f. Orale Chirurgie u. Röntgenologi
Full Title: Einfluss von peroraler Methylprednisolon-Gabe auf die postoperative Morbidität nach operativer Weisheitszahnenfernung im Unterkiefer. (Influence of peroral Methylprednisolone administration on the...
Medical condition: To be investigated is the anti-inflammatory and anti-oedematous effect of methylprednisolone on the postoperative sequelae after surgical removal of lower third molars. 16 healthy patients will und...
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results

EudraCT Number: 2008-002039-34

Sponsor Protocol Number: CABF656B2202

Start Date*: 2008-12-15

Sponsor Name:Novartis Pharma Services AG

Full Title: An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...

Medical condition: chronic hepatitis C

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10008912	Chronic hepatitis C	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) ES (Completed) FR (Completed) PL (Completed) IT (Completed) GR (Prematurely Ended) GB (Completed)

Trial results: View results

EudraCT Number: 2008-002069-30	Sponsor Protocol Number: 13069	Start Date*: 2008-12-05
Sponsor Name:Bayer Vital GmbH
Full Title: A randomized, double-blind, single centre, placebo-controlled pilot study to assess on a molecular level the influence of a 5 % dexpanthenol ointment in subjects with previously injured skin by inv...
Medical condition: Biopsy wounds on healthy volunteers
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2007-005011-25

Sponsor Protocol Number: PR88302

Start Date*: 2008-02-13

Sponsor Name:Progen Pharmaceuticals Limited

Full Title: A prospective, randomised, double-blind, placebo-controlled, parallel-group, international multicentre phase III trial of PI-88 in the adjuvant treatment of post-resection hepatocellular carcinoma ...

Medical condition: post-resection hepatocellular carcinoma Carcinoma hepatocelular post-resección

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10019830	Hepatocellular carcinoma resectable	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing) IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2007-005022-71

Sponsor Protocol Number: C-II-004

Start Date*: 2008-01-17

Sponsor Name:CESAR Central European Society for Anticancer Drug Research – EWIV

Full Title: Prospective randomized Phase II trial with gemcitabine plus sunitinib versus gemcitabine alone in first-line therapy of metastatic or locally advanced pancreatic cancer

Medical condition: metastatic or locally advanced pancreatic cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10033575	Pancreas cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2005-004993-26

Sponsor Protocol Number: CSPP100A2351

Start Date*: 2006-05-05

Sponsor Name:Novartis Pharma Services AG

Full Title: A nine-week, randomized, double-blind, parallel group study to evaluate the efficacy and safety of aliskiren 300 mg, compared to irbesartan 300 mg and ramipril 10 mg in the setting of a missed dose...

Medical condition: Hypertension

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.1		10020772

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SK (Completed) ES (Completed) IT (Completed) HU (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2008-000938-49	Sponsor Protocol Number: PT026/08/01	Start Date*: 2008-08-18
Sponsor Name:Proteo Biotech AG
Full Title: Placebo-controlled Randomized Trial to evaluate the Effect of Elafin on Cytokine Profiles after Major Surgery - Phase II
Medical condition: Esophagectomy is the surgical removal of all or part of the esophagus. The patients enrolled in the study will undergo this surgery for treatment of esophageal cancer. The condition under investig...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

EudraCT Number: 2007-000257-56	Sponsor Protocol Number: EB065	Start Date*: 2007-02-05
Sponsor Name:Emotional Brain BV
Full Title: Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural co...
Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder
Disease:
Population Age: Adults		Gender: Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-000261-38	Sponsor Protocol Number: 108988	Start Date*: 2008-01-21
Sponsor Name:GlaxoSmithKline Biologicals
Full Title: A phase IV, open, multicentric study to evaluate the immune response to a hepatitis B challenge dose in healthy subjects, 72 to 78 months after they received a primary vaccination course of GSK Bio...
Medical condition: Hepatitis B vaccine challenge dose given to subjects, 17 to 21 years of age, to evaluate immune memory to Hepatitis B antigen, approximately 6 years after priming with Hepatitis B vaccine.
Disease:
Population Age: Adolescents, Under 18, Adults		Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results

EudraCT Number: 2007-000262-20

Sponsor Protocol Number: DPOD III

Start Date*: 2007-07-25

Sponsor Name:Stanmore Clinical Research Facility Ltd

Full Title: A phase III, 7 days randomised, double-blind, placebo-controlled, parallel group study to assess efficacy of DPZ for reducing the symptoms of post-operative delirium after an elective hip or knee r...

Medical condition: Post-operative delirium.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10012218	Delirium	LLT

Population Age: Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2007-000270-23

Sponsor Protocol Number: Z BEAM 2

Start Date*: 2007-05-21

Sponsor Name:GELA

Full Title: TARGETED INTENSIFICATION BY A PREPARATIVE REGIMEN FOR PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMA UTILIZING STANDARD-DOSE YTTRIUM-90 IBRITUMOMAB TIUXETAN (ZEVALIN) RADIOIMMUNOTHERAPY (RIT) COMBINED WI...

Medical condition: Diffuse Large B cell Lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10012818	Diffuse large B-cell lymphoma	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

EudraCT Number: 2007-000275-42

Sponsor Protocol Number: IIL/DLCL04

Start Date*: 2006-01-20

Sponsor Name:IIL INTERGRUPPO ITALIANO LINFOMI ONLUS

Full Title: A phase III, multicentric randomized study for the treatment of young patients with unfavorable prognosis Diffuse Large Cell B Lymphoma IPI 2-3 . Dose-dense chemotherapy Rituximab +/- intens...

Medical condition: Patients with Diffuse Large B Cell Lymphoma.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:			10012826		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2007-003111-31	Sponsor Protocol Number: 2007-1-18-20-6	Start Date*: 2008-07-21
Sponsor Name:Charité - Universitaetsmedizin Berlin
Full Title: Influence of postoperative influenza vaccination versus GM-CSF in immune-compromised patients undergoing pancreatic or esophageal resection on the course of immunosuppression and the postoperative ...
Medical condition: Post-operative immunological stimulation in severe immune suppression. The study population is made up of adult, which are able to give their inform consent by their own. The patients are undergoin...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2007-003133-16

Sponsor Protocol Number: P04875

Start Date*: 2008-02-15

Sponsor Name:SCHERING-PLOUGH

Full Title: Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects

Medical condition: HIV INFECTION IN NAIVE PATIENTS

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10020161	HIV infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended) ES (Prematurely Ended) PT (Prematurely Ended) DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2006-005283-47

Sponsor Protocol Number: P903-07

Start Date*: 2006-12-29

Sponsor Name:Cerexa, Inc.

Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin plus Aztreonam in Adult Subjects with Complicated Skin and ...

Medical condition: Complicated Skin and Skin Structure Infections (cSSSI)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10052891	Skin bacterial infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) GB (Completed) DE (Completed) LV (Completed)

Trial results: View results

EudraCT Number: 2006-005287-94

Sponsor Protocol Number: Stulnig_PUFA1

Start Date*: 2008-05-06

Sponsor Name:Medizinische Universität Wien

Full Title: Impact of n-3 Polyunsaturated Fatty Acids on Adipose Tissue Inflammation in Morbidly Obese Patients

Medical condition: morbid obesity

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10027966	Morbid obesity	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: AT (Completed)

Trial results: View results

EudraCT Number: 2007-005135-28

Sponsor Protocol Number: 1184.13

Start Date*: 2008-03-27

Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co.KG

Full Title: A randomised, double–blind, crossover efficacy and safety comparison of Tiotropium/Salmeterol (7.5 µg/ 25 µg) Inhalation Powder in the morning (PE Capsule via tiotropium/salmeterol HandiHaler®), Ti...

Medical condition: Patients of either sex, 40 years of age or older, and with a diagnosis of moderate to severe COPD

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2007-005151-42

Sponsor Protocol Number: P05101

Start Date*: 2008-08-28

Sponsor Name:Schering Plough Research Institute, A Division of Schering Corporation

Full Title: A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin

Medical condition: Chronic Hepatitis C

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10008912	Chronic hepatitis C	LLT
	9.1		10019744	Hepatitis C	PT
	9.1		10021881	Infections and infestations	SOC
	9.1		10019805	Hepatobiliary disorders	SOC

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) PT (Prematurely Ended) ES (Completed) IT (Completed) BE (Completed) DE (Completed) GB (Prematurely Ended)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Sat Feb 14 21:02:20 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA